Disease ⇒ Urinary stone disease {40000161}

Record Keys

Parent:[  ]
Urinary stone disease


Initialisation date:
Other Terms:
Urinary Calculi, Nephrolithiasis, Stones, Urolithiasis


Meta Information

MedDra ID:[  ]
MedDra Level:[  ]
ICD:[  ]
Zone:[  ]
Mechanism:[  ]


[  ]

Shared Reference Notes

  • [1.1
    - Lactobacillus may inhibit stone growth. However, our multi-omics integration strongly points to three unknown metabolites. - The bacterium Oxalobacter formigenes uses oxalate as a carbon and energy source for growth, is negatively associated with both USD and urinary oxalate, is sensitive to common antibiotics, and can reduce urinary oxalate when administered orally as a probiotic, all of which implicates loss of function dysbiosis associated with this species and calcium oxalate stone formation.
  • [1.2] [#Antibiotic Therapy
    - antibiotics cause a rapid loss of gut microbial #oxalate metabolism, and while disturbed bacteria can partially recover over time, the ability to metabolize #oxalate does not. - This results in the accumulation of oxalates in the body and increases the risk of kidney stones.
  • [1.3] [#Kidney stone
  • [1.4] [#Kidney stone
    - #Vitamin A deficiency has been shown to reduce urinary #Citrate and pH, and to increase the presence of urinary calculi. - Supplementation with high amounts of #Vitamin A (retinol) in a calcium oxalate stone rat model enhanced urinary #Citrate levels, increased urinary pH, and lowered the concentration of calcium and oxalate in renal tissues
  • [#Vitamin A] - #Children with ≤0.25 mg/l serum retinol showed impaired gut barrier function, as determined by the #Mannitol/#lactulose test. - reduced intestinal permeability could reduce #oxalate uptake and, consequently, the formation of calcium #oxalate stones.

References Notes

[  ]

Common References

MetaBiom uses only essential session cookies to give you a perfect experience on the website. By selecting "Accept essential Cookies" you agree the use of these cookies.